Drug Type Cell therapy |
Synonyms Anti Third Party Veto Cell Cell Source, Organsource, Tcentral memory Veto Cell Cell Source |
Target- |
Action- |
Mechanism Cell replacements, Immunosuppressants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Virus Diseases | Phase 2 | United States | 01 Sep 2019 | |
| Graft vs Host Disease | Phase 2 | United States | 29 Jul 2019 | |
| Anemia, Sickle Cell | Preclinical | Israel | - | |
| Graft Rejection | Preclinical | Israel | - |





